Liposomal oligonucleotide compositions

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/70 (2006.01) A61K 9/127 (2006.01) C12N 15/11 (2006.01)

Patent

CA 2227989

A pharmaceutical composition comprising (A) an oligonucleotide 8 to 50 nucleotides in length, which is targeted to mRNA encoding human raf and is capable of inhibiting raf expression, entrapped in (B) sterically stabilised liposomes.

Composition pharmaceutique qui comprend (A) un oligonucléotide ayant de 8 à 50 nucléotides de longueur, qui a pour cible l'ARNm codant raf humain, et est capable d'inhiber l'expression de raf, piégé dans des (B) liposomes à stabilisation stérique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Liposomal oligonucleotide compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liposomal oligonucleotide compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposomal oligonucleotide compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2043970

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.